This is a double blind study with a single subject to objectively document the clinical effects of bupropion and citalopram in a single patient with Friedreich Ataxia (FA), whose disorder symptoms have improved with the use of these medications.
The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.